Male Breast Cancer Completed Phase 3 Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01638247Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer PatientsTreatment